Drug intelligence / Profile preview

hesperidin + naringin

Development stage
Preclinical
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Hesperidin + naringin is a combination of two citrus flavonoids, both naturally occurring polyphenolic compounds found in citrus fruits. This combination has been studied for its potential antioxidant, anti-inflammatory, and antiapoptotic effects. Preclinical studies indicate that the combined administration of hesperidin and naringin can counteract drug-induced liver injury (such as diclofenac-induced hepatotoxicity) by reducing oxidative stress markers, inflammatory cytokines (e.g., TNF-α, IL-17), and apoptotic gene expression (p53, caspase-3), while increasing protective factors like glutathione content and antioxidant enzyme activities (GPx, SOD). The combination appears more potent than either compound alone in these models[2]. Both compounds are also individually used or studied for vascular health benefits such as improving symptoms of chronic venous insufficiency and hemorrhoids[1].

02

Targets

LYZ (Lysozyme C)Sucrase-IsomaltaseMMP8 (Neutrophil collagenase)PRSS1 (Trypsin family)MMP12 (Macrophage Metalloelastase)

Beyond the preview

Go deeper on hesperidin + naringin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hesperidin + naringin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call